Thousands of pregnant women are struggling to cope with the effects of the Zika virus and are being tested to see if they have it, but experts are warning that the disease is deadly and that pregnant women should not be given the drug ZMapp.
Key points:The baby-boom generation is being affected by the virusA new report has found more than 1.5 million pregnant women in the US are infected with ZikaThe US is still grappling with the virus and the potential for spread The number of cases is increasing in the states of Texas, Florida, Georgia and Puerto Rico.
“There is a fear that if we give people ZMamp, they will spread it to other people and then the number of infections will increase,” Dr John Fauci, a paediatrician at the University of Alabama School of Medicine in Birmingham, told the ABC.
“We are still dealing with the spread of Zika, and there is a lot of concern about it.”
Dr Faucs new report, published in the American Journal of Tropical Medicine and Hygiene, found that 1.7 million pregnant people in the United States were infected with the Zika strain, including nearly 2.6 million in the first month of the pandemic.
“A significant proportion of pregnant people have received ZMap in the last 24 hours,” Dr Fauces team wrote.
“They have not reported any symptoms or symptoms of the virus or any other illness, and the number and severity of Zika-related illnesses have increased.”
The team found that more than 637,000 women in those states were tested for the Zika infection.
“The virus is a highly virulent virus, and it is hard to be completely sure of the extent of the impact that it has on pregnant women,” Dr David Fauck, director of the CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NCANID), said in a statement.
“As a consequence, our primary concern is the number who have the virus.
The vast majority of pregnant and breastfeeding women should continue to receive ZMav as recommended, even though the vaccine does not work as well.”
The US has been in a state of emergency since the beginning of the crisis in late February, with authorities ramping up the screening of pregnant pregnant women.
“While we are confident in the effectiveness of ZMmap as a treatment for Zika, we are very concerned about the number in our country,” Dr J. Paul Smith, an infectious disease specialist at the US Centers for Disease Control and Prevention, said in an interview with ABC News.
Dr Faus new findings came just days after a report by the US Public Health Service warned that more people in New York City than anywhere else in the country are infected, with more than 8,000 cases.
The city is also experiencing the worst outbreak of the coronavirus in its history, with nearly half of all New Yorkers diagnosed with the disease.
“This outbreak in New Yorkers is unprecedented, and we need to do everything we can to help our communities in New Yorks,” Dr Smith said.
“I think there are so many more questions that need to be asked.”
He said he believed the New York case rate would be lower than the national rate of one in five, with many New Yorkers who had previously tested negative showing no symptoms.
He said it was “quite possible” that there was no true transmission of the strain.
“It is quite possible that the virus has not been fully distributed to New York.
It may be that it is spread through a number of people and people are not aware of it,” Dr Johnson said.
In addition to the New Yorkers, the outbreak has also affected Atlanta, Nashville, Houston, Sacramento, St Louis, Tampa, Seattle and Portland, Oregon.
The US Department of Health and Human Services (HHS) has already approved the drug for use in pregnant women with Zika.